Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants. (2023). SKIN The Journal of Cutaneous Medicine, 7(4), s227. https://doi.org/10.25251/skin.7.supp.227